Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Total Non-Current Liabilities: 2014-2025

Historic Total Non-Current Liabilities for BIO-TECHNE (TECH) over the last 11 years, with Sep 2025 value amounting to $536.5 million.

  • BIO-TECHNE's Total Non-Current Liabilities fell 7.11% to $536.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $536.5 million, marking a year-over-year decrease of 7.11%. This contributed to the annual value of $612.0 million for FY2025, which is 1.59% down from last year.
  • According to the latest figures from Q3 2025, BIO-TECHNE's Total Non-Current Liabilities is $536.5 million, which was down 12.33% from $612.0 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Total Non-Current Liabilities peaked at $749.8 million during Q4 2023, and registered a low of $512.9 million during Q1 2021.
  • In the last 3 years, BIO-TECHNE's Total Non-Current Liabilities had a median value of $621.9 million in 2024 and averaged $644.8 million.
  • As far as peak fluctuations go, BIO-TECHNE's Total Non-Current Liabilities declined by 24.54% in 2021, and later spiked by 42.84% in 2023.
  • Over the past 5 years, BIO-TECHNE's Total Non-Current Liabilities (Quarterly) stood at $590.1 million in 2021, then fell by 11.04% to $525.0 million in 2022, then soared by 42.84% to $749.8 million in 2023, then fell by 22.57% to $580.6 million in 2024, then fell by 7.11% to $536.5 million in 2025.
  • Its last three reported values are $536.5 million in Q3 2025, $612.0 million for Q2 2025, and $610.6 million during Q1 2025.